Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20324443

Targeting NF-κB in Waldenstrom macroglobulinemia

Author
LELEU, Xavier1 2 ; EECKHOUTE, Jérome1 ; BURWICK, Nicolas1 ; AZAB, Abdelkareem1 ; AZAB, Feda1 ; HUNTER, Zachary1 ; HATJIHARISSI, Evdoxia1 ; CARRASCO, Daniel R1 ; TREON, Steven P1 ; WITZIG, Thomas E3 ; HIDESHIMA, Teru1 ; BROWN, Myles1 ; XIAOYING JIA1 ; ANDERSON, Kenneth C1 ; GHOBRIAL, Irene M4 ; ROCCARO, Aldo M1 ; MOREAU, Anne-Sophie1 2 ; FARAG, Mena1 ; SACCO, Antonio1 ; NGO, Hai T1 ; RUNNELS, Judith1 ; MELHEM, Molly R1
[1] Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States
[2] Service des Maladies du Sang et Laboratoire d'lmmunologie, CHRU, Lille, France
[3] Division of Hematology, Mayo Clinic, Rochester, MN, United States
[4] Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States
Source

Blood. 2008, Vol 111, Num 10, pp 5068-5077, 10 p ; ref : 48 ref

ISSN
0006-4971
Scientific domain
Medical oncology; Hematology
Publisher
The Americain Society of Hematology, Washington, DC
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Bortézomib Chimiothérapie Ciblage Cytotoxicité Facteur transcription NFκB Homme Immunothérapie Macroglobulinémie de Waldenström Rituximab Traitement associé Traitement Transduction signal Antigène CD20 Anticorps monoclonal Anticytokine Cancer Hémopathie maligne Immunoglobulinopathie Immunomodulateur Immunopathologie Lymphocyte B Syndrome lymphoprolifératif
Keyword (en)
Antineoplastic agent Bortezomib Chemotherapy Targeting Cytotoxicity Transcription factor NFκB Human Immunotherapy Waldenström macroglobulinemia Rituximab Combined treatment Treatment Signal transduction Monoclonal antibody Anticytokine Cancer Malignant hemopathy Immunoglobulinopathy Immunomodulator Immunopathology B-Lymphocyte Lymphoproliferative syndrome
Keyword (es)
Anticanceroso Bortezomib Quimioterapia Blancado Citotoxicidad Factor transcripción NFκB Hombre Inmunoterapia Macroglobulinemia Waldenström Rituximab Tratamiento asociado Tratamiento Transducción señal Anticuerpo monoclonal Anticitoquina Cáncer Hemopatía maligna Inmunoglobulinopatía Inmunomodulador Inmunopatología Linfocito B Linfoproliferativo síndrome
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D02 Immunoglobulinopathies

Discipline
Immunopathology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20324443

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web